Periodontal disease, which affects the gums and tissues that surround the teeth, is one of the most prevalent dental conditions worldwide.
Marinomed Biotech AG resolves second capital increase excluding statutory subscription rights by issuing 83,750 no-par value bearer shares at an issue price of EUR 8 per share – Biotech Investments
Marinomed Biotech AG / Key word(s): Corporate Action/Capital Increase Marinomed Biotech AG resolves second capital increase excluding statutory subscription rights by issuing 83,750 no-par value